Company Filing History:
Years Active: 2024
Title: The Innovations of Marc Horst Peter Hild
Introduction
Marc Horst Peter Hild is an accomplished inventor based in Wellesley, MA (US). He has made significant contributions to the field of protein degradation through his innovative research and development. His work has the potential to impact various applications in biotechnology and medicine.
Latest Patents
Hild holds a patent for "Compositions and methods for selective protein degradation." This invention provides compositions that include a fusion polypeptide and methods for creating a fusion polypeptide that incorporates a COF1/CRBN-binding polypeptide, COF2/CRBN-binding polypeptide, or COF3/CRBN-binding polypeptide along with a heterologous polypeptide of interest. This patent highlights his expertise in the area of protein engineering and degradation.
Career Highlights
Marc Hild is currently associated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to collaborate with other experts in the field and contribute to groundbreaking research. His work is recognized for its potential to advance therapeutic strategies in treating various diseases.
Collaborations
Hild has worked alongside notable colleagues such as James Bradner and Andrei Alexandrovich Golosov. These collaborations have fostered an environment of innovation and have led to significant advancements in their respective fields.
Conclusion
Marc Horst Peter Hild is a prominent inventor whose work in selective protein degradation is paving the way for future innovations in biotechnology. His contributions to Novartis AG and collaborations with esteemed colleagues further enhance his impact in the scientific community.